| Primary |
| Product Used For Unknown Indication |
26.9% |
| Vertigo |
14.9% |
| Drug Use For Unknown Indication |
9.0% |
| Dizziness |
7.5% |
| Anxiety |
6.0% |
| Motion Sickness |
4.5% |
| Rheumatoid Arthritis |
4.5% |
| Suicide Attempt |
4.5% |
| Akathisia |
3.0% |
| Nausea |
3.0% |
| Pain |
3.0% |
| Abdominal Discomfort |
1.5% |
| Accidental Overdose |
1.5% |
| Antiallergic Therapy |
1.5% |
| Bipolar Disorder |
1.5% |
| Blood Potassium |
1.5% |
| Blood Pressure Increased |
1.5% |
| Decreased Activity |
1.5% |
| Fluid Retention |
1.5% |
| Gastrooesophageal Reflux Disease |
1.5% |
|
| Hallucination, Visual |
11.1% |
| Vision Blurred |
11.1% |
| Death |
8.3% |
| Gait Disturbance |
8.3% |
| Drug Exposure During Pregnancy |
5.6% |
| Drug Ineffective |
5.6% |
| Heart Disease Congenital |
5.6% |
| Mental Status Changes |
5.6% |
| Nightmare |
5.6% |
| Vertigo |
5.6% |
| Abdominal Discomfort |
2.8% |
| Confusional State |
2.8% |
| Disease Recurrence |
2.8% |
| Eye Pain |
2.8% |
| Grand Mal Convulsion |
2.8% |
| Hallucination |
2.8% |
| Headache |
2.8% |
| Heart Rate Increased |
2.8% |
| Hyperhidrosis |
2.8% |
| Hypersensitivity |
2.8% |
|
| Secondary |
| Product Used For Unknown Indication |
27.2% |
| Rheumatoid Arthritis |
9.4% |
| Anxiety |
7.3% |
| Drug Use For Unknown Indication |
6.5% |
| Vertigo |
6.1% |
| Dizziness |
5.5% |
| Foetal Exposure During Pregnancy |
5.2% |
| Drug Exposure During Pregnancy |
4.6% |
| Depression |
4.0% |
| Ill-defined Disorder |
3.8% |
| Akathisia |
3.1% |
| Hallucination |
3.1% |
| Pain |
2.3% |
| Suicide Attempt |
1.9% |
| Hypertension |
1.7% |
| Motion Sickness |
1.7% |
| Nausea |
1.7% |
| Restless Legs Syndrome |
1.7% |
| Smoking Cessation Therapy |
1.7% |
| Muscle Relaxant Therapy |
1.5% |
|
| Completed Suicide |
16.5% |
| Psychotic Disorder |
8.2% |
| Unresponsive To Stimuli |
8.2% |
| Drug Toxicity |
7.2% |
| Toxicity To Various Agents |
6.2% |
| Vertigo |
6.2% |
| Cystic Lymphangioma |
4.1% |
| Dizziness |
4.1% |
| Drug Hypersensitivity |
4.1% |
| Weight Increased |
4.1% |
| Cardiac Arrest |
3.1% |
| Cardio-respiratory Arrest |
3.1% |
| Hallucination |
3.1% |
| Headache |
3.1% |
| Hunger |
3.1% |
| Inappropriate Schedule Of Drug Administration |
3.1% |
| Nausea |
3.1% |
| Overdose |
3.1% |
| Pain In Extremity |
3.1% |
| Poisoning |
3.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
30.5% |
| Drug Use For Unknown Indication |
20.2% |
| Pain |
6.0% |
| Hypertension |
4.9% |
| Dizziness |
4.2% |
| Multiple Sclerosis |
3.9% |
| Depression |
3.6% |
| Vertigo |
3.3% |
| Gastrooesophageal Reflux Disease |
3.0% |
| Rheumatoid Arthritis |
2.6% |
| Anxiety |
2.5% |
| Osteoporosis |
2.3% |
| Nausea |
2.1% |
| Asthma |
2.0% |
| Diabetes Mellitus |
2.0% |
| Blood Cholesterol Increased |
1.5% |
| Atrial Fibrillation |
1.4% |
| Arthritis |
1.4% |
| Chronic Obstructive Pulmonary Disease |
1.3% |
| Insomnia |
1.3% |
|
| Vomiting |
14.0% |
| Weight Decreased |
11.6% |
| Weight Increased |
7.5% |
| Vertigo |
6.9% |
| Urinary Tract Infection |
6.3% |
| Pain |
5.3% |
| Tremor |
5.1% |
| Type 2 Diabetes Mellitus |
4.4% |
| Nausea |
4.2% |
| Pulmonary Embolism |
3.9% |
| Vision Blurred |
3.9% |
| Thrombosis |
3.5% |
| Cerebrovascular Accident |
3.3% |
| Dizziness |
3.3% |
| Drug Ineffective |
2.9% |
| Myocardial Infarction |
2.9% |
| Syncope |
2.9% |
| Transient Ischaemic Attack |
2.9% |
| White Blood Cell Count Decreased |
2.9% |
| Pain In Extremity |
2.7% |
|
| Interacting |
| Gastrooesophageal Reflux Disease |
15.8% |
| Anticoagulant Therapy |
10.5% |
| Blood Cholesterol Increased |
10.5% |
| Dementia |
10.5% |
| Dizziness |
10.5% |
| Hypertension |
10.5% |
| Bipolar Disorder |
5.3% |
| Convulsion |
5.3% |
| Grand Mal Convulsion |
5.3% |
| Pain |
5.3% |
| Sarcoma |
5.3% |
| Thyroid Disorder |
5.3% |
|
| Abnormal Behaviour |
20.0% |
| Dyspnoea |
20.0% |
| Grand Mal Convulsion |
20.0% |
| Hallucination |
20.0% |
| Weight Decreased |
20.0% |
|
